Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Application of the adverse outcome pathway framework to genotoxic modes of action.

Sasaki JC, Allemang A, Bryce SM, Custer L, Dearfield KL, Dietz Y, Elhajouji A, Escobar PA, Fornace AJ Jr, Froetschl R, Galloway S, Hemmann U, Hendriks G, Li HH, Luijten M, Ouedraogo G, Peel L, Pfuhler S, Roberts DJ, Thybaud V, van Benthem J, Yauk CL, Schuler M.

Environ Mol Mutagen. 2019 Oct 11. doi: 10.1002/em.22339. [Epub ahead of print]

PMID:
31603995
2.

Evidence for an Aneugenic Mechanism of Action for Micronucleus Induction by Black Cohosh Extract.

Bernacki DT, Bryce SM, Bemis JC, Dertinger SD, Witt KL, Smith-Roe SL.

Environ Mol Mutagen. 2019 Dec;60(9):845-856. doi: 10.1002/em.22334. Epub 2019 Oct 30.

PMID:
31569270
3.

Thematic analysis of youth mental health providers' perceptions of neuropsychological assessment services.

Delagneau G, Bowden SC, Bryce S, van-der-El K, Hamilton M, Adams S, Burgat L, Killackey E, Rickwood D, Allott K.

Early Interv Psychiatry. 2019 Sep 11. doi: 10.1111/eip.12876. [Epub ahead of print]

PMID:
31512388
4.

Perceived need for neuropsychological assessment according to geographic location: A survey of Australian youth mental health clinicians.

Delagneau G, Bowden SC, van-der-El K, Bryce S, Hamilton M, Adams S, Burgat L, Killackey E, Rickwood D, Allott K.

Appl Neuropsychol Child. 2019 Jul 14:1-10. doi: 10.1080/21622965.2019.1624170. [Epub ahead of print]

PMID:
31303056
5.

Neurocognitive and Self-efficacy Benefits of Cognitive Remediation in Schizophrenia: A Randomized Controlled Trial - Corrigendum.

Bryce SD, Rossell SL, Lee SJ, Lawrence RJ, Tan EJ, Carruthers SP, Ponsford JL.

J Int Neuropsychol Soc. 2019 Jul;25(6):659-660. doi: 10.1017/S1355617719000535. No abstract available.

PMID:
31290385
6.

Subjective experiences of neurocognitive functioning in young people with major depression.

Morey-Nase C, Phillips LJ, Bryce S, Hetrick S, Wright AL, Caruana E, Allott K.

BMC Psychiatry. 2019 Jul 4;19(1):209. doi: 10.1186/s12888-019-2197-1.

7.

Aneugen Molecular Mechanism Assay: Proof-of-Concept With 27 Reference Chemicals.

Bernacki DT, Bryce SM, Bemis JC, Dertinger SD.

Toxicol Sci. 2019 Aug 1;170(2):382-393. doi: 10.1093/toxsci/kfz123.

PMID:
31132080
8.

Novel Technological Advances in Functional Connectomics in C. elegans.

DiLoreto EM, Chute CD, Bryce S, Srinivasan J.

J Dev Biol. 2019 Apr 23;7(2). pii: E8. doi: 10.3390/jdb7020008. Review.

9.

Emotional discomfort mediates the relationship between self-efficacy and subjective quality of life in people with schizophrenia.

Lee SJ, Lawrence R, Bryce S, Ponsford J, Tan EJ, Rossell SL.

J Ment Health. 2019 Mar 16:1-7. doi: 10.1080/09638237.2019.1581355. [Epub ahead of print]

PMID:
30879374
10.

Cognitive screening: A significant unmet need in youth mental health.

Bryce S, Allott K.

Aust N Z J Psychiatry. 2019 Aug;53(8):813. doi: 10.1177/0004867419834356. Epub 2019 Mar 8. No abstract available.

PMID:
30848664
11.

Predictions of genotoxic potential, mode of action, molecular targets, and potency via a tiered multiflow® assay data analysis strategy.

Dertinger SD, Kraynak AR, Wheeldon RP, Bernacki DT, Bryce SM, Hall N, Bemis JC, Galloway SM, Escobar PA, Johnson GE.

Environ Mol Mutagen. 2019 Jul;60(6):513-533. doi: 10.1002/em.22274. Epub 2019 Feb 27.

PMID:
30702769
12.

How cognitive remediation can be utilized strategically to enhance social and independent living self-efficacy.

Bryce SD, Ponsford JL, Tan EJ, Rossell SL, Lee SJ.

Schizophr Res. 2019 Feb;204:421-422. doi: 10.1016/j.schres.2018.08.010. Epub 2018 Aug 23. No abstract available.

PMID:
30145065
13.

TGFβ inhibition restores a regenerative response in acute liver injury by suppressing paracrine senescence.

Bird TG, Müller M, Boulter L, Vincent DF, Ridgway RA, Lopez-Guadamillas E, Lu WY, Jamieson T, Govaere O, Campbell AD, Ferreira-Gonzalez S, Cole AM, Hay T, Simpson KJ, Clark W, Hedley A, Clarke M, Gentaz P, Nixon C, Bryce S, Kiourtis C, Sprangers J, Nibbs RJB, Van Rooijen N, Bartholin L, McGreal SR, Apte U, Barry ST, Iredale JP, Clarke AR, Serrano M, Roskams TA, Sansom OJ, Forbes SJ.

Sci Transl Med. 2018 Aug 15;10(454). pii: eaan1230. doi: 10.1126/scitranslmed.aan1230.

14.

Understanding the lived experience of cognitive remediation in schizophrenia: A qualitative comparison with an active control.

Bryce S, Warren N, Ponsford J, Rossell S, Lee S.

Psychiatr Rehabil J. 2018 Dec;41(4):302-311. doi: 10.1037/prj0000309. Epub 2018 Jul 16.

PMID:
30010356
15.

Vocational engagement among young people entering mental health treatment compared with their general population peers.

Caruana E, Farhall J, Cotton SM, Parrish E, van-der-El K, Davey CG, Chanen AM, Bryce SD, Killackey E, Allott K.

Early Interv Psychiatry. 2019 Jun;13(3):692-696. doi: 10.1111/eip.12712. Epub 2018 Jul 3.

PMID:
29968285
16.

The impact of intrinsic motivation on session attendance and reliable cognitive improvement in cognitive remediation in schizophrenia.

Bryce SD, Lee SJ, Ponsford JL, Lawrence RJ, Tan EJ, Rossell SL.

Schizophr Res. 2018 Dec;202:354-360. doi: 10.1016/j.schres.2018.06.028. Epub 2018 Jun 21.

PMID:
29935884
17.

Black cohosh extracts and powders induce micronuclei, a biomarker of genetic damage, in human cells.

Smith-Roe SL, Swartz CD, Shepard KG, Bryce SM, Dertinger SD, Waidyanatha S, Kissling GE, Auerbach SS, Witt KL.

Environ Mol Mutagen. 2018 Jun;59(5):416-426. doi: 10.1002/em.22182. Epub 2018 Apr 18.

18.

EnLightenment: High resolution smartphone microscopy as an educational and public engagement platform.

Wicks LC, Cairns GS, Melnyk J, Bryce S, Duncan RR, Dalgarno PA.

Wellcome Open Res. 2017 Nov 6;2:107. doi: 10.12688/wellcomeopenres.12841.2. eCollection 2017.

19.

Comparative Genotoxicity of TEMPO and 3 of Its Derivatives in Mouse Lymphoma Cells.

Guo X, Seo JE, Bryce SM, Tan JA, Wu Q, Dial SL, Moore MM, Mei N.

Toxicol Sci. 2018 May 1;163(1):214-225. doi: 10.1093/toxsci/kfy022.

20.

Neurocognitive and Self-efficacy Benefits of Cognitive Remediation in Schizophrenia: A Randomized Controlled Trial.

Bryce SD, Rossell SL, Lee SJ, Lawrence RJ, Tan EJ, Carruthers SP, Ponsford JL.

J Int Neuropsychol Soc. 2018 Jul;24(6):549-562. doi: 10.1017/S1355617717001369. Epub 2018 Jan 21. Erratum in: J Int Neuropsychol Soc. 2019 Jul;25(6):659-660.

PMID:
29352823
21.

Investigating the Generalizability of the MultiFlow ® DNA Damage Assay and Several Companion Machine Learning Models With a Set of 103 Diverse Test Chemicals.

Bryce SM, Bernacki DT, Smith-Roe SL, Witt KL, Bemis JC, Dertinger SD.

Toxicol Sci. 2018 Mar 1;162(1):146-166. doi: 10.1093/toxsci/kfx235.

22.

Emotion regulation as a transdiagnostic treatment construct across anxiety, depression, substance, eating and borderline personality disorders: A systematic review.

Sloan E, Hall K, Moulding R, Bryce S, Mildred H, Staiger PK.

Clin Psychol Rev. 2017 Nov;57:141-163. doi: 10.1016/j.cpr.2017.09.002. Epub 2017 Sep 11. Review.

PMID:
28941927
23.

Interlaboratory evaluation of a multiplexed high information content in vitro genotoxicity assay.

Bryce SM, Bernacki DT, Bemis JC, Spellman RA, Engel ME, Schuler M, Lorge E, Heikkinen PT, Hemmann U, Thybaud V, Wilde S, Queisser N, Sutter A, Zeller A, Guérard M, Kirkland D, Dertinger SD.

Environ Mol Mutagen. 2017 Apr;58(3):146-161. doi: 10.1002/em.22083.

24.

Note from the HRSA Guest Editors.

Hutchings A, Young S, Bryce S, Newton H, Phillips C, Berrian A.

J Health Care Poor Underserved. 2016;27(4A):xiii-xv. No abstract available.

PMID:
27818406
25.

γH2AX and p53 responses in TK6 cells discriminate promutagens and nongenotoxicants in the presence of rat liver S9.

Bernacki DT, Bryce SM, Bemis JC, Kirkland D, Dertinger SD.

Environ Mol Mutagen. 2016 Aug;57(7):546-558. doi: 10.1002/em.22028. Epub 2016 Jul 1.

26.

ACKR4 on Stromal Cells Scavenges CCL19 To Enable CCR7-Dependent Trafficking of APCs from Inflamed Skin to Lymph Nodes.

Bryce SA, Wilson RA, Tiplady EM, Asquith DL, Bromley SK, Luster AD, Graham GJ, Nibbs RJ.

J Immunol. 2016 Apr 15;196(8):3341-53. doi: 10.4049/jimmunol.1501542. Epub 2016 Mar 14.

27.

Cognitive remediation in schizophrenia: A methodological appraisal of systematic reviews and meta-analyses.

Bryce S, Sloan E, Lee S, Ponsford J, Rossell S.

J Psychiatr Res. 2016 Apr;75:91-106. doi: 10.1016/j.jpsychires.2016.01.004. Epub 2016 Jan 5. Review.

PMID:
26828372
28.

Best practices for application of attachment cells to in vitro micronucleus assessment by flow cytometry.

Bemis JC, Bryce SM, Nern M, Raschke M, Sutter A.

Mutat Res Genet Toxicol Environ Mutagen. 2016 Jan 1;795:51-9. doi: 10.1016/j.mrgentox.2015.10.007. Epub 2015 Nov 2.

PMID:
26774667
29.

Genotoxic mode of action predictions from a multiplexed flow cytometric assay and a machine learning approach.

Bryce SM, Bernacki DT, Bemis JC, Dertinger SD.

Environ Mol Mutagen. 2016 Apr;57(3):171-89. doi: 10.1002/em.21996. Epub 2016 Jan 13.

30.

Flow cytometric evaluation of the contribution of ionic silver to genotoxic potential of nanosilver in human liver HepG2 and colon Caco2 cells.

Sahu SC, Njoroge J, Bryce SM, Zheng J, Ihrie J.

J Appl Toxicol. 2016 Apr;36(4):521-31. doi: 10.1002/jat.3276. Epub 2016 Jan 6.

PMID:
26732652
31.

Does cognitive performance map to categorical diagnoses of schizophrenia, schizoaffective disorder and bipolar disorder? A discriminant functions analysis.

Van Rheenen TE, Bryce S, Tan EJ, Neill E, Gurvich C, Louise S, Rossell SL.

J Affect Disord. 2016 Mar 1;192:109-15. doi: 10.1016/j.jad.2015.12.022. Epub 2015 Dec 17.

PMID:
26720009
32.

Desire for greater clarity when defining 'cognitive remediation' in reviews of treatment efficacy for schizophrenia.

Bryce SD, Lee SJ, Ponsford JL, Rossell SL.

Aust N Z J Psychiatry. 2016 May;50(5):497. doi: 10.1177/0004867415617838. Epub 2015 Nov 24. No abstract available.

PMID:
26607301
33.

Nutrition in remote Aboriginal communities: lessons from Mai Wiru and the Anangu Pitjantjatjara Yankunytjatjara Lands.

Lee A, Rainow S, Tregenza J, Tregenza L, Balmer L, Bryce S, Paddy M, Sheard J, Schomburgk D.

Aust N Z J Public Health. 2016 Apr;40 Suppl 1:S81-8. doi: 10.1111/1753-6405.12419. Epub 2015 Aug 10.

PMID:
26260761
34.

Mouse Pig-a and micronucleus assays respond to N-ethyl-N-nitrosourea, benzo[a]pyrene, and ethyl carbamate, but not pyrene or methyl carbamate.

Labash C, Avlasevich SL, Carlson K, Berg A, Torous DK, Bryce SM, Bemis JC, MacGregor JT, Dertinger SD.

Environ Mol Mutagen. 2016 Jan;57(1):28-40. doi: 10.1002/em.21965. Epub 2015 Jul 17.

PMID:
26186091
35.

Comparison of in vitro and in vivo clastogenic potency based on benchmark dose analysis of flow cytometric micronucleus data.

Bemis JC, Wills JW, Bryce SM, Torous DK, Dertinger SD, Slob W.

Mutagenesis. 2016 May;31(3):277-85. doi: 10.1093/mutage/gev041. Epub 2015 Jun 6.

36.

Targeting cell migration in rheumatoid arthritis.

Asquith DL, Bryce SA, Nibbs RJ.

Curr Opin Rheumatol. 2015 Mar;27(2):204-11. doi: 10.1097/BOR.0000000000000150. Review.

PMID:
25603038
37.

Screening for Substance Use Disorders Following Traumatic Brain Injury: Examining the Validity of the AUDIT and the DAST.

Bryce S, Spitz G, Ponsford J.

J Head Trauma Rehabil. 2015 Sep-Oct;30(5):E40-8. doi: 10.1097/HTR.0000000000000091.

PMID:
25310295
38.

Comparative genotoxicity of nanosilver in human liver HepG2 and colon Caco2 cells evaluated by a flow cytometric in vitro micronucleus assay.

Sahu SC, Njoroge J, Bryce SM, Yourick JJ, Sprando RL.

J Appl Toxicol. 2014 Nov;34(11):1226-34. doi: 10.1002/jat.3065. Epub 2014 Sep 16.

PMID:
25224830
39.

Interpreting in vitro micronucleus positive results: simple biomarker matrix discriminates clastogens, aneugens, and misleading positive agents.

Bryce SM, Bemis JC, Mereness JA, Spellman RA, Moss J, Dickinson D, Schuler MJ, Dertinger SD.

Environ Mol Mutagen. 2014 Aug;55(7):542-55. doi: 10.1002/em.21868. Epub 2014 Apr 23.

PMID:
24756928
40.

Experiences of a community pharmacy service to support adherence and self-management in chronic heart failure.

Lowrie R, Johansson L, Forsyth P, Bryce SL, McKellar S, Fitzgerald N.

Int J Clin Pharm. 2014 Feb;36(1):154-62. doi: 10.1007/s11096-013-9889-2. Epub 2013 Nov 30.

PMID:
24293306
41.

Is consumer response to plain/standardised tobacco packaging consistent with framework convention on tobacco control guidelines? A systematic review of quantitative studies.

Stead M, Moodie C, Angus K, Bauld L, McNeill A, Thomas J, Hastings G, Hinds K, O'Mara-Eves A, Kwan I, Purves RI, Bryce SL.

PLoS One. 2013 Oct 16;8(10):e75919. doi: 10.1371/journal.pone.0075919. eCollection 2013. Review.

42.

Genetic stability of bone marrow-derived human mesenchymal stromal cells in the Quantum System.

Jones M, Varella-Garcia M, Skokan M, Bryce S, Schowinsky J, Peters R, Vang B, Brecheisen M, Startz T, Frank N, Nankervis B.

Cytotherapy. 2013 Nov;15(11):1323-39. doi: 10.1016/j.jcyt.2013.05.024. Epub 2013 Aug 28.

43.

Trauma in the pregnant patient: an evidence-based approach to management.

Smith KA, Bryce S.

Emerg Med Pract. 2013 Apr;15(4):1-18; quiz 18-9. Review.

PMID:
23847860
44.

Flow cytometric 96-well microplate-based in vitro micronucleus assay with human TK6 cells: protocol optimization and transferability assessment.

Bryce SM, Avlasevich SL, Bemis JC, Tate M, Walmsley RM, Saad F, Van Dijck K, De Boeck M, Van Goethem F, Lukamowicz-Rajska M, Elhajouji A, Dertinger SD.

Environ Mol Mutagen. 2013 Apr;54(3):180-94. doi: 10.1002/em.21760. Epub 2013 Feb 27.

PMID:
23447390
45.

Efficient monitoring of in vivo pig-a gene mutation and chromosomal damage: summary of 7 published studies and results from 11 new reference compounds.

Dertinger SD, Phonethepswath S, Avlasevich SL, Torous DK, Mereness J, Bryce SM, Bemis JC, Bell S, Weller P, Macgregor JT.

Toxicol Sci. 2012 Dec;130(2):328-48. doi: 10.1093/toxsci/kfs258. Epub 2012 Aug 24.

46.

In vivo flow cytometric Pig-a and micronucleus assays: highly sensitive discrimination of the carcinogen/noncarcinogen pair benzo(a)pyrene and pyrene using acute and repeated-dose designs.

Torous DK, Phonethepswath S, Avlasevich SL, Mereness J, Bryce SM, Bemis JC, Weller P, Bell S, Gleason C, Custer LL, MacGregor JT, Dertinger SD.

Environ Mol Mutagen. 2012 Jul;53(6):420-8. doi: 10.1002/em.21709. Epub 2012 Jun 22.

PMID:
22730284
47.

Interlaboratory Pig-a gene mutation assay trial: Studies of 1,3-propane sultone with immunomagnetic enrichment of mutant erythrocytes.

Dertinger SD, Phonethepswath S, Weller P, Avlasevich S, Torous DK, Mereness JA, Bryce SM, Bemis JC, Bell S, Portugal S, Aylott M, MacGregor JT.

Environ Mol Mutagen. 2011 Dec;52(9):748-55. doi: 10.1002/em.20671. Epub 2011 Aug 29.

PMID:
22052433
48.

When pigs fly: immunomagnetic separation facilitates rapid determination of Pig-a mutant frequency by flow cytometric analysis.

Dertinger SD, Bryce SM, Phonethepswath S, Avlasevich SL.

Mutat Res. 2011 Apr 3;721(2):163-70. doi: 10.1016/j.mrgentox.2011.01.009. Epub 2011 Jan 28.

49.

The effect of cognitive impairment on the accuracy of the presenting complaint and discharge instruction comprehension in older emergency department patients.

Han JH, Bryce SN, Ely EW, Kripalani S, Morandi A, Shintani A, Jackson JC, Storrow AB, Dittus RS, Schnelle J.

Ann Emerg Med. 2011 Jun;57(6):662-671.e2. doi: 10.1016/j.annemergmed.2010.12.002. Epub 2011 Jan 26.

50.

Flow cytometric analysis of micronuclei in mammalian cell cultures: past, present and future.

Avlasevich S, Bryce S, De Boeck M, Elhajouji A, Van Goethem F, Lynch A, Nicolette J, Shi J, Dertinger S.

Mutagenesis. 2011 Jan;26(1):147-52. doi: 10.1093/mutage/geq058. Review.

PMID:
21164196

Supplemental Content

Support Center